oxazolidin-2-one has been researched along with Anti-MuSK Myasthenia Gravis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ichiyama, S; Ito, Y; Matsumoto, R; Matsumura, Y; Matsushima, A; Nagao, M; Tabu, H; Takahashi, R; Takakura, S; Tanioka, K; Uemura, K; Yamamoto, M | 1 |
| Cawley, MJ; Lipka, O | 1 |
2 other study(ies) available for oxazolidin-2-one and Anti-MuSK Myasthenia Gravis
| Article | Year |
|---|---|
Disseminated Nocardia farcinica infection in a patient with myasthenia gravis successfully treated by linezolid: a case report and literature review.
Topics: Acetamides; Anti-Bacterial Agents; Drug Hypersensitivity; Female; Humans; Linezolid; Middle Aged; Myasthenia Gravis; Nocardia; Nocardia Infections; Oxazolidinones | 2012 |
Intravenous linezolid administered orally: a novel desensitization strategy.
Topics: Acetamides; Administration, Oral; Adult; Anti-Infective Agents; Desensitization, Immunologic; Drug Resistance, Microbial; Enterococcus; Enterococcus faecium; Female; Humans; Linezolid; Myasthenia Gravis; Oxazolidinones | 2006 |